Please assess the completion status of the following clinical trial:

Trial Title: Augmentation Cystoplasty Using an Autologous Neo-Bladder

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* subjects with neurogenic bladders secondary to myleodysplasia~Exclusion Criteria:~* prior augment procedures~* recent urologic surgery~* requires concomitant urologic intervention

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Neo-bladder construction (Type: EXPERIMENTAL): Surgical implantation of autologous neo-bladder construct

Based on this trial design, predict the completion outcome and termination type (if applicable).